Inactivated Influenza Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Inactivated Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Influenza Vaccine Overall Market Size
2.1 Global Inactivated Influenza Vaccine Market Size: 2022 VS 2035
2.2 Global Inactivated Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Inactivated Influenza Vaccine Sales: 2018-2035
3 Company Landscape
3.1 Top Inactivated Influenza Vaccine Players in Global Market
3.2 Top Global Inactivated Influenza Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Influenza Vaccine Revenue by Companies
3.4 Global Inactivated Influenza Vaccine Sales by Companies
3.5 Global Inactivated Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inactivated Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inactivated Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inactivated Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Inactivated Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Inactivated Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Influenza Vaccine Market Size Markets, 2022 & 2035
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - Global Inactivated Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Inactivated Influenza Vaccine Revenue, 2024-2035
4.2.3 By Type - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
4.3 By Type - Global Inactivated Influenza Vaccine Sales & Forecasts
4.3.1 By Type - Global Inactivated Influenza Vaccine Sales, 2018-2023
4.3.2 By Type - Global Inactivated Influenza Vaccine Sales, 2024-2035
4.3.3 By Type - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
4.4 By Type - Global Inactivated Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Influenza Vaccine Market Size, 2022 & 2035
5.1.2 Children
5.1.3 Adolescence
5.1.4 Adults
5.1.5 Elderly
5.2 By Application - Global Inactivated Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Inactivated Influenza Vaccine Revenue, 2024-2035
5.2.3 By Application - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
5.3 By Application - Global Inactivated Influenza Vaccine Sales & Forecasts
5.3.1 By Application - Global Inactivated Influenza Vaccine Sales, 2018-2023
5.3.2 By Application - Global Inactivated Influenza Vaccine Sales, 2024-2035
5.3.3 By Application - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
5.4 By Application - Global Inactivated Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Inactivated Influenza Vaccine Market Size, 2022 & 2035
6.2 By Region - Global Inactivated Influenza Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Inactivated Influenza Vaccine Revenue, 2024-2035
6.2.3 By Region - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
6.3 By Region - Global Inactivated Influenza Vaccine Sales & Forecasts
6.3.1 By Region - Global Inactivated Influenza Vaccine Sales, 2018-2023
6.3.2 By Region - Global Inactivated Influenza Vaccine Sales, 2024-2035
6.3.3 By Region - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Inactivated Influenza Vaccine Revenue, 2018-2035
6.4.2 By Country - North America Inactivated Influenza Vaccine Sales, 2018-2035
6.4.3 US Inactivated Influenza Vaccine Market Size, 2018-2035
6.4.4 Canada Inactivated Influenza Vaccine Market Size, 2018-2035
6.4.5 Mexico Inactivated Influenza Vaccine Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Inactivated Influenza Vaccine Revenue, 2018-2035
6.5.2 By Country - Europe Inactivated Influenza Vaccine Sales, 2018-2035
6.5.3 Germany Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.4 France Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.5 U.K. Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.6 Italy Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.7 Russia Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.8 Nordic Countries Inactivated Influenza Vaccine Market Size, 2018-2035
6.5.9 Benelux Inactivated Influenza Vaccine Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Inactivated Influenza Vaccine Revenue, 2018-2035
6.6.2 By Region - Asia Inactivated Influenza Vaccine Sales, 2018-2035
6.6.3 China Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.4 Japan Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.5 South Korea Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.6 Southeast Asia Inactivated Influenza Vaccine Market Size, 2018-2035
6.6.7 India Inactivated Influenza Vaccine Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Inactivated Influenza Vaccine Revenue, 2018-2035
6.7.2 By Country - South America Inactivated Influenza Vaccine Sales, 2018-2035
6.7.3 Brazil Inactivated Influenza Vaccine Market Size, 2018-2035
6.7.4 Argentina Inactivated Influenza Vaccine Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Inactivated Influenza Vaccine Sales, 2018-2035
6.8.3 Turkey Inactivated Influenza Vaccine Market Size, 2018-2035
6.8.4 Israel Inactivated Influenza Vaccine Market Size, 2018-2035
6.8.5 Saudi Arabia Inactivated Influenza Vaccine Market Size, 2018-2035
6.8.6 UAE Inactivated Influenza Vaccine Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 CSL Limited
7.1.1 CSL Limited Company Summary
7.1.2 CSL Limited Business Overview
7.1.3 CSL Limited Inactivated Influenza Vaccine Major Product Offerings
7.1.4 CSL Limited Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CSL Limited Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Inactivated Influenza Vaccine Major Product Offerings
7.2.4 GSK Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi Pasteur
7.3.1 Sanofi Pasteur Company Summary
7.3.2 Sanofi Pasteur Business Overview
7.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Major Product Offerings
7.3.4 Sanofi Pasteur Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Pasteur Key News & Latest Developments
7.4 Viatris
7.4.1 Viatris Company Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Inactivated Influenza Vaccine Major Product Offerings
7.4.4 Viatris Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Viatris Key News & Latest Developments
7.5 Hualan Biological
7.5.1 Hualan Biological Company Summary
7.5.2 Hualan Biological Business Overview
7.5.3 Hualan Biological Inactivated Influenza Vaccine Major Product Offerings
7.5.4 Hualan Biological Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Hualan Biological Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Inactivated Influenza Vaccine Major Product Offerings
7.6.4 AstraZeneca Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Sinovac Biotech
7.7.1 Sinovac Biotech Company Summary
7.7.2 Sinovac Biotech Business Overview
7.7.3 Sinovac Biotech Inactivated Influenza Vaccine Major Product Offerings
7.7.4 Sinovac Biotech Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Sinovac Biotech Key News & Latest Developments
7.8 Aleph Biomedical
7.8.1 Aleph Biomedical Company Summary
7.8.2 Aleph Biomedical Business Overview
7.8.3 Aleph Biomedical Inactivated Influenza Vaccine Major Product Offerings
7.8.4 Aleph Biomedical Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Aleph Biomedical Key News & Latest Developments
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Company Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Inactivated Influenza Vaccine Major Product Offerings
7.9.4 Abbott Laboratories Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Laboratories Key News & Latest Developments
7.10 Novartis International
7.10.1 Novartis International Company Summary
7.10.2 Novartis International Business Overview
7.10.3 Novartis International Inactivated Influenza Vaccine Major Product Offerings
7.10.4 Novartis International Inactivated Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Novartis International Key News & Latest Developments
8 Global Inactivated Influenza Vaccine Production Capacity, Analysis
8.1 Global Inactivated Influenza Vaccine Production Capacity, 2018-2035
8.2 Inactivated Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Inactivated Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inactivated Influenza Vaccine Supply Chain Analysis
10.1 Inactivated Influenza Vaccine Industry Value Chain
10.2 Inactivated Influenza Vaccine Upstream Market
10.3 Inactivated Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inactivated Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Inactivated Influenza Vaccine in Global Market
Table 2. Top Inactivated Influenza Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Inactivated Influenza Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Inactivated Influenza Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Inactivated Influenza Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Inactivated Influenza Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Inactivated Influenza Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Inactivated Influenza Vaccine Product Type
Table 9. List of Global Tier 1 Inactivated Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Influenza Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Inactivated Influenza Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Inactivated Influenza Vaccine Sales (K Units), 2024-2035
Table 16. By Application ? Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Inactivated Influenza Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Inactivated Influenza Vaccine Sales (K Units), 2024-2035
Table 21. By Region ? Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Inactivated Influenza Vaccine Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Inactivated Influenza Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Inactivated Influenza Vaccine Sales (K Units), 2024-2035
Table 26. By Country - North America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Inactivated Influenza Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Inactivated Influenza Vaccine Sales, (K Units), 2024-2035
Table 30. By Country - Europe Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Inactivated Influenza Vaccine Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Inactivated Influenza Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Inactivated Influenza Vaccine Sales, (K Units), 2024-2035
Table 34. By Region - Asia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Inactivated Influenza Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Inactivated Influenza Vaccine Sales, (K Units), 2024-2035
Table 38. By Country - South America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Inactivated Influenza Vaccine Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Inactivated Influenza Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Inactivated Influenza Vaccine Sales, (K Units), 2024-2035
Table 42. By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Inactivated Influenza Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Inactivated Influenza Vaccine Sales, (K Units), 2024-2035
Table 46. CSL Limited Company Summary
Table 47. CSL Limited Inactivated Influenza Vaccine Product Offerings
Table 48. CSL Limited Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. CSL Limited Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Inactivated Influenza Vaccine Product Offerings
Table 52. GSK Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Pasteur Company Summary
Table 55. Sanofi Pasteur Inactivated Influenza Vaccine Product Offerings
Table 56. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Pasteur Key News & Latest Developments
Table 58. Viatris Company Summary
Table 59. Viatris Inactivated Influenza Vaccine Product Offerings
Table 60. Viatris Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Viatris Key News & Latest Developments
Table 62. Hualan Biological Company Summary
Table 63. Hualan Biological Inactivated Influenza Vaccine Product Offerings
Table 64. Hualan Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Hualan Biological Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Inactivated Influenza Vaccine Product Offerings
Table 68. AstraZeneca Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Sinovac Biotech Company Summary
Table 71. Sinovac Biotech Inactivated Influenza Vaccine Product Offerings
Table 72. Sinovac Biotech Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Sinovac Biotech Key News & Latest Developments
Table 74. Aleph Biomedical Company Summary
Table 75. Aleph Biomedical Inactivated Influenza Vaccine Product Offerings
Table 76. Aleph Biomedical Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Aleph Biomedical Key News & Latest Developments
Table 78. Abbott Laboratories Company Summary
Table 79. Abbott Laboratories Inactivated Influenza Vaccine Product Offerings
Table 80. Abbott Laboratories Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Abbott Laboratories Key News & Latest Developments
Table 82. Novartis International Company Summary
Table 83. Novartis International Inactivated Influenza Vaccine Product Offerings
Table 84. Novartis International Inactivated Influenza Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Novartis International Key News & Latest Developments
Table 86. Inactivated Influenza Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Inactivated Influenza Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Inactivated Influenza Vaccine Production by Region, 2018-2023 (K Units)
Table 89. Global Inactivated Influenza Vaccine Production by Region, 2024-2035 (K Units)
Table 90. Inactivated Influenza Vaccine Market Opportunities & Trends in Global Market
Table 91. Inactivated Influenza Vaccine Market Drivers in Global Market
Table 92. Inactivated Influenza Vaccine Market Restraints in Global Market
Table 93. Inactivated Influenza Vaccine Raw Materials
Table 94. Inactivated Influenza Vaccine Raw Materials Suppliers in Global Market
Table 95. Typical Inactivated Influenza Vaccine Downstream
Table 96. Inactivated Influenza Vaccine Downstream Clients in Global Market
Table 97. Inactivated Influenza Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inactivated Influenza Vaccine Segment by Type in 2022
Figure 2. Inactivated Influenza Vaccine Segment by Application in 2022
Figure 3. Global Inactivated Influenza Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Inactivated Influenza Vaccine Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Inactivated Influenza Vaccine Revenue, 2018-2035 (US$, Mn)
Figure 7. Inactivated Influenza Vaccine Sales in Global Market: 2018-2035 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Inactivated Influenza Vaccine Revenue in 2022
Figure 9. By Type - Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 11. By Type - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 12. By Type - Global Inactivated Influenza Vaccine Price (US$/Unit), 2018-2035
Figure 13. By Application - Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 15. By Application - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 16. By Application - Global Inactivated Influenza Vaccine Price (US$/Unit), 2018-2035
Figure 17. By Region - Global Inactivated Influenza Vaccine Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Inactivated Influenza Vaccine Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 20. By Region - Global Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 21. By Country - North America Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 22. By Country - North America Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 23. US Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 28. Germany Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 29. France Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 37. China Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 41. India Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 43. By Country - South America Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 44. Brazil Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Inactivated Influenza Vaccine Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Inactivated Influenza Vaccine Sales Market Share, 2018-2035
Figure 48. Turkey Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Inactivated Influenza Vaccine Revenue, (US$, Mn), 2018-2035
Figure 52. Global Inactivated Influenza Vaccine Production Capacity (K Units), 2018-2035
Figure 53. The Percentage of Production Inactivated Influenza Vaccine by Region, 2022 VS 2035
Figure 54. Inactivated Influenza Vaccine Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
